Recombinant Human Erythropoietin Injection IP

Product Description

Recombinant Human Erythropoietin Injection IP is a synthetic form of erythropoietin (EPO), a hormone that is naturally produced by the kidneys to stimulate the production of red blood cells (RBCs) in the bone marrow. It helps maintain hemoglobin levels in dialysis patients, improving their overall well-being. This is primarily used to treat anemia caused by various medical conditions, particularly those that result in decreased red blood cell production. It Improves quality of life by alleviating symptoms of anemia, such as fatigue and weakness. Recombinant Human Erythropoietin Injection IP improves quality of life by alleviating symptoms of anemia, such as fatigue and weakness.

Product Type - Recombinant Human Erythropoietin Injection IP

Self Life - 1.5 To 2 Years 

Usage - Commercial